Andere talen Wockhardt Limited

Aandelen

WOCKPHARMA

INE049B01025

Vertraagde tijd NSE India S.E. Andere beurzen 12:28:18 22-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
542,5 ^INR	+1,21%		-0,23%	+27,84%

03/04	Wockhardt Limited kondigt ontslag van onafhankelijke bestuurders aan	CI
14/02	Wockhardt Limited meldt resultaten voor het derde kwartaal en de negen maanden eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Wockhardt Limited Announces Cessation of Independent Directors	03/04
Aziwok vs Aziwake: Delhi High Court Grants Interim Injunction In Light Of Rival Marks Being Closely Similar For Azithromycin	08/03
Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Wockhardt Limited Announces Successful Completion of Pivotal Phase 3 Pneumonia Study of Its Macrolide Antibody Nafithromycin WCK 4873	11/12
Wockhardt Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11
CARE Cuts Rating on Wockhardt's Working Capital to BB+; Outlook Negative	06-09-23
Wockhardt Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14-08-23
Wockhardt Limited Announces Executive Changes	14-08-23
CARE Keeps BBB- Rating on Wockhardt's Bank Financing	07-06-23
Wockhardt Trims Consolidated Loss in Fiscal Q4	29-05-23
Wockhardt Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	26-05-23
INDIA STOCKS-Indian shares fall on rate-hike worries ahead of Fed, RBI minutes	22-02-23
Wockhardt Widens Consolidated Net Profit in Fiscal Q3	14-02-23
Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13-02-23
Wockhardt Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	04-11-22
CARE Keeps Rating on Wockhardt's Long-term Bank Financing, Bonds; Outlook Stable	05-09-22
Wockhardt : Corp Restructuring - others	20-08-22
Wockhardt Starts Global Phase 3 Clinical Study of Novel Antibiotic WCK 5222	16-08-22
Wockhardt Announces Successful Initiation of Global Phase 3 Clinical Study of Its Novel Antibiotic WCK 5222	16-08-22
Wockhardt Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	12-08-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Wockhardt Limited

Aandelen

WOCKPHARMA

INE049B01025

Andere talen

Filters